{"title":"利拉鲁肽使双相情感障碍患者的体重明显减轻","authors":"","doi":"10.1002/pu.31179","DOIUrl":null,"url":null,"abstract":"<p>A 40-week study has found that obese or overweight individuals with stable bipolar disorder who received liraglutide lost significantly more body weight than individuals receiving placebo. Liraglutide was associated with few adverse events and no exacerbation of psychopathology.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Liraglutide results in significant weight loss in patients with bipolar disorder\",\"authors\":\"\",\"doi\":\"10.1002/pu.31179\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A 40-week study has found that obese or overweight individuals with stable bipolar disorder who received liraglutide lost significantly more body weight than individuals receiving placebo. Liraglutide was associated with few adverse events and no exacerbation of psychopathology.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31179\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Liraglutide results in significant weight loss in patients with bipolar disorder
A 40-week study has found that obese or overweight individuals with stable bipolar disorder who received liraglutide lost significantly more body weight than individuals receiving placebo. Liraglutide was associated with few adverse events and no exacerbation of psychopathology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
